ArticleJournal of pharmacy & bioallied sciences2025
Assessing the Risks of Prenatal Radiation: Effects on Pregnancy and Neonatal Development.
Article in Journal of pharmacy & bioallied sciences, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: Prenatal radiation exposure raises significant concerns regarding its effects on pregnancy and neonatal health, particularly regarding increased risks of adverse outcomes. This study aims to evaluate these risks and their association with varying radiation doses. Aim of the Study: To assess the impact of prenatal radiation exposure on pregnancy outcomes and neonatal development among pregnant women in Bangladesh. Methods: A sample of 120 pregnant women was recruited from Bangladesh Medical College Hospital and other private hospitals between 2023 and 2024. Participants were classified by age, gestational age at exposure, and type of radiation received. Key outcomes measured included miscarriages, preterm births, congenital anomalies, low birth weight, and neurodevelopmental delays, categorized into three exposure groups: <100 mGy, 100-200 mGy, and >200 mGy. Results: The study found a clear dose-dependent relationship between radiation exposure and adverse outcomes. Among the <100 mGy group, there were 2 miscarriages and 2 congenital anomalies. In the 100-200 mGy group, there were 6 miscarriages and 8 congenital anomalies, while the >200 mGy group exhibited the highest rates with 10 miscarriages and 10 congenital anomalies. Additionally, average birth weights decreased with higher exposure levels: 3200 g in the <100 mGy group compared to 2800 g in the >200 mGy group. Conclusion: These findings highlight the critical need for careful assessment and management of radiation exposure during pregnancy to minimize risks to maternal and fetal health. The study underscores the importance of informed decision-making and adherence to radiation safety protocols in clinical practice.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.